NPPB and cancer: In REgistry on TAKOtsubo Syndrome (RETAKO), 463 patients were included (median age 73 years, 13% men), and higher levels of heart failure (HF) and inflammatory markers such as N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity CRP (hs-CRP) were identified as predictors of late recovery [16.0% vs. 8.6%, adjusted hazard ratio (HR): 1.31; 95% confidence interval (CI): 1.12–1.60] and increased severity in TTS patients with cancer (adjusted HR: 1.08; 95% CI: 1.04–1.13) [31].